ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,342.50
3.00 (0.22%)
27 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.00 0.22% 1,342.50 1,340.00 1,340.50 1,345.00 1,335.50 1,338.00 3,344,130 16:35:12
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1889 11.28 55.52B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,339.50p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,119,334 shares in issue. The market capitalisation of Gsk is £55.52 billion. Gsk has a price to earnings ratio (PE ratio) of 11.28.

Gsk Share Discussion Threads

Showing 1201 to 1224 of 34150 messages
Chat Pages: Latest  58  57  56  55  54  53  52  51  50  49  48  47  Older
DateSubjectAuthorDiscuss
20/4/2009
08:45
GlaxoSmithKline on Monday said it's paying at least $2.9 billion in cash to buy privately-held Stiefel Laboratories.
miata
20/4/2009
08:18
up to £11.00+ in my opinion, buy confirmed on britishbulls.com
thebull3
20/4/2009
06:28
from Bloomberg ... GlaxoSmithKline PLC (GSK LN): The world's second-biggest drugmaker may be near an agreement to acquire Stiefel Laboratories Inc. for about $3 billion, the Wall Street Journal reported on its Web site, without saying where it got the information. The shares rose 3 pence, or 0.3 percent, to 1,038 pence.
analyzer
18/4/2009
18:40
Amended 1171 - adr's indicate we should open higher on Mon!
sat69
18/4/2009
17:45
Suspect range change due, think we go higher this week,
chutes01
18/4/2009
07:27
Yesterday harvested the full premium on my written april 880 put option .
I have high hopes that the written may and june 880 put options will also be succesful. I feel tempted to go forward further in time for more option writing but think I wait for results first, even though that may mean a price jump and lesser premium.

harvester
18/4/2009
06:42
And judging by the adr's it looks like we'll be opening HIGHER on Monday. With results due on Wednesday though, the trading range is about to change, but to what....?
sat69
17/4/2009
22:40
In and out like a fiddler's elbow - 3 times previously I have said "get in at 1000ish" - does anyone listen? Yeah - no brainer indeed! If you haven't made cash on GSK over the last 6 weeks, then I would give up now!
eisler
17/4/2009
19:01
Position closed - time to wait for £10 again!
sat69
15/4/2009
10:50
Eisler.....many here have bought in at £10. No brainer.
oilgetmecoat
15/4/2009
10:42
Don't want to say "told you so" but..."told you so"
eisler
15/4/2009
07:33
Rising nicely. Back in profit but hope I can hang on till at least 1050p this time!
sat69
14/4/2009
08:19
Q1 results next week - GSK always please!
sat69
14/4/2009
08:11
so am i. this should be the floor
juju43
14/4/2009
07:58
Back in again - £10.
sat69
08/4/2009
16:34
Eisler - You'll be able to get in at £10 again soon - maybe tomorrow?
sat69
04/4/2009
07:50
The Israeli pharma firm Teva has been touted as being a beneficiary of tighter medicare spending. Why buy expensive Glaxo when you can by cheaper generic drugs?May buy some when they next drop(usually when Israel looks like it's up the creek) to hedge my Gsk holding. I think that is what Buffett has done
spondon2
04/4/2009
07:22
Eisler - you are missing the point - harvester WROTE put options - he will pocket the full premium.
alphorn
03/4/2009
21:56
A cracking coupla weeks of in-and-out with GSK - £1.6k in the coffers - so much for the "875p here we come" merchants! What bit of "get in at £10" did they not understand? Right, second chance. If you see GSK touch 1000-1020, get in - meaning buy them - that means BUY them...i.e. when the little box on your screen says "buy or sell" - select the "buy" option... Christ - look at the graph - it aint rocket science! But as ever, DYOR, IMHO, CYA and good luck!
eisler
03/4/2009
16:35
Ah well, at least you can look forward to receiving your divi next week!
sat69
03/4/2009
16:29
Or maybe not!
kingsdock
03/4/2009
07:47
GSK was upgraded to outperform from in-line by Cazenove, with the broker seeing an attractive risk profile at an attractive valuation. The broker also said there's upside from its pipeline, citing the drug Avodart for prostate cancer prevention which could add 500 million pounds onto the broker's 2013 sales forecasts and lift earnings by around 5%.

Should help th share price today

kingsdock
01/4/2009
16:42
How many pence/share is the divi?
spondon2
31/3/2009
09:17
Breakout started.
chutes01
Chat Pages: Latest  58  57  56  55  54  53  52  51  50  49  48  47  Older

Your Recent History

Delayed Upgrade Clock